Insights Into Hims & Hers Health Inc (HIMS) Exposure By Institutions

After Hours

It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Most recently, Yahoo Finance reported about the stock as it publicized that Hims & Hers Health, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Stocks Info

Hims & Hers Health Inc is listed on the NYSE in the Consumer Defensive sector while operating in the Household & Personal Products industry. At the end of the last regular session, the stock closed at $14.24 and fluctuated between $14.58 as its day high and $13.91 as its day low. The current market capitalization of Hims & Hers Health Inc is $3.05B. A total of 7.46 million shares were traded on the day, compared to an average of 3.82M shares.

Insider Activity

Insider trades are also considered as indicators of how a stock will perform in the future, in addition to stock predictions. During the recent three months, HIMS has seen 0 BUY and 0 SELL insider trades, representing the acquisition of 0 and the disposition of 0 shares. Over the last 12 months, there were 63 BUYs and 81 SELLs from insiders. Insiders purchased 1,812,467 shares during that period but sold 1,344,098.

In the most recent transaction, Okupe Oluyemi sold 50,574 shares of HIMS for 13.55 per share on Mar 04. After the transaction, the Chief Financial Officer now owns 146,674 company shares. In a previous transaction on Mar 04, Becklund Irene sold 17,930 shares at 14.50 per share. HIMS shares that PAO owns now total 2,747.

Among the insiders who sold shares, Dudum Andrew disposed of 240,549 shares on Mar 01 at a per-share price of $13.07. This resulted in the Chief Executive Officer holding 0 shares of HIMS after the transaction. In another insider transaction, Dudum Andrew sold 144,448 shares at $13.07 per share on Mar 01. Company shares held by the Chief Executive Officer now total 1,599,310.

Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, HIMS has a high of $14.89 and a low of $5.65.

As of this writing, HIMS has an earnings estimate of $0.01 per share for the current quarter. EPS was calculated based on a consensus of 7 estimates, with a high estimate of $0.02 per share and a lower estimate of -$0.04. The company reported an EPS of -$0.04 in the last quarter, which was -33.30% lower than expectations of -$0.03.

Balance Sheet Annually/Quarterly

As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. HIMS’s latest balance sheet shows that the firm has $247.27M in Cash & Short Term Investments as of fiscal 2021. There were $5.48M in debt and $79.22M in liabilities at the time. Its Book Value Per Share was $1.61, while its Total Shareholder’s Equity was $334.62M.

Analysts Opinion

After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for HIMS is Buy with a score of 4.08.

Most Popular

Related Posts